TY  - BOOK
AU  - Bleyer, Archie (ed)
AU  - Barr, Ronald (ed)
AU  - Ries, Lynn (ed)
AU  - Whelan, Jeremy (ed)
AU  - Ferrari, Andrea (ed)
TI  - Cancer in adolescents and young adults
SN  - 3319336770
PY  - 2017///
CY  - Switzerland
PB  - Springer International
KW  - Oncology
KW  - Paediatric Cancer
KW  - Adolescence
N1  - Adolescent and young adult oncology : historical and global prespectives; Cancer incidence, survival and mortality among adolescents and young adults; The biology of AYA cancers; Non-hodgkin lymphoma; Hodgkin lymphoma; Acute myelogenous leukemia; Acute lymphoblastic leukemis; Breast cancer before 40; Thyroid cancer; Malignant melanoma in the adolescent and young adult population; Cancer of the ovary, uterus and cervis; testicular cancer; Colorectal and anal tumors; Soft tissue sarcoma; Bone sarcomas in the adolescent and young adult population; Cancer of the kidney, bladder and prostate; Liver tumors; Other carcinomas; Access and models of care; Clinical trials; Adherence to treatment regimes in adolescent and young adult cancer patients; Psychosocial issues in adolescent and young adult patients and survivors; Sexual consequences of cancer and its treatment in adolescents and young adults; Fertility preservation in pediatric setting; Rehabilitation and exercise; Making ends meet - financial issues from the perspectives of patients and their health-care team; Adolescent and young adult cancer survivors - late effects of treatment; Promoting health and care transitions in the long-term AYA survivor; Health-related quality of life; Palliative care; Addressing the ethical challenges for young adults from a rights-based perspective; Economic evaluation in adolescent and young adult cancer - methodological considerations and the state of the science; DRAFT: AYA advocacy in action - achievments, lessons, and challenges from a global movement for change; Conclusions, perspectives, and future considerations
N2  - This is the second edition of the only book to be devoted exclusively to the total cancer picture in adolescents and young adults (AYA), now expanded from the age range 15-29 to that of 15–39 years. For each of the diverse spectrum of cancers encountered in the AYA group, the epidemiology, natural progression, diagnostic approaches, and treatment options are described, with special emphasis on strategies for early detection and prevention
ER  -